CBD Composition for Diabetes With Weight and Lipid Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for diabetes, obesity, and associated metabolic disorders such as high triglyceride and cholesterol levels are inadequate in effectively reducing body weight and improving lipid profiles.

Innovation Solution

Compositions comprising cannabidiol (CBD) in specific ratios with high oleic acid sunflower oil, sodium bicarbonate, bile salt extracts, and carriers like gum Arabic or tapioca starch, which are administered to subjects to treat diabetes and improve metabolic parameters.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current treatments for diabetes and metabolic disorders are used, then blood glucose levels may be controlled, but body weight reduction and improvement of lipid profiles (triglycerides and cholesterol) are inadequate

Engineering Contradiction:
Improveefficacy in reducing body weight and improving lipid profilesVSAvoidcomprehensive metabolic improvement
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent combines multiple therapeutic agents into a single composition: cannabidiol (CBD) for glucose control and weight management, high oleic acid sunflower oil for lipid profile improvement, sodium bicarbonate for metabolic balance, and bile salt extracts for cholesterol management. This merged formulation addresses multiple metabolic parameters simultaneously, resolving the contradiction between reliable glucose control and comprehensive metabolic improvement.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The treatment uses a composite formulation with specifically selected ingredients and ratios. The composite nature of the composition allows synergistic effects where CBD provides anti-diabetic and weight-loss benefits, high oleic acid sunflower oil improves triglyceride and cholesterol levels, and bile salt extracts further enhance lipid metabolism, achieving comprehensive metabolic improvement that single-agent treatments cannot provide.

Inventive Principle:
Principle #40Composite materials

2Adaptability or versatility

If single-agent treatments are used for diabetes, then specific symptoms may be addressed, but multiple metabolic parameters (body weight, triglycerides, cholesterol) cannot be improved simultaneously

Engineering Contradiction:
Improveability to treat multiple metabolic disordersVSAvoidtreatment composition complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The treatment composition is designed with multi-functionality: cannabidiol addresses blood glucose control and body weight reduction, high oleic acid sunflower oil targets triglyceride and cholesterol improvement, sodium bicarbonate supports metabolic balance, and bile salt extracts enhance lipid metabolism. This universal formulation can treat diabetes, obesity, and dyslipidemia simultaneously, making the treatment adaptable to multiple metabolic disorders while managing complexity through a fixed, optimized composition.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS20250387416A1Compositions and methods for treating diabetes
Publication Date: 2025.12.25 POVIVA CORP
  • US20250387416A1 patent drawing
  • US20250387416A1 patent drawing
  • US20250387416A1 patent drawing

AI summary

Disclosed herein are compositions and methods for treating diabetes. The disclosed compositions are also effective for reducing body weight and improving triglyceride and cholesterol levels.